dc.contributor.author |
Maserumule, L.C. (Letjie)
|
|
dc.contributor.author |
Okoala, K.M.G. (Kgomotso)
|
|
dc.contributor.author |
Van de Wiele, Christophe
|
|
dc.contributor.author |
Popoola, Gbenga
|
|
dc.contributor.author |
Hlongwa, Khanyisile N.
|
|
dc.contributor.author |
Ndlovu, Honest
|
|
dc.contributor.author |
Maes, Alex
|
|
dc.contributor.author |
Vorster, Mariza
|
|
dc.contributor.author |
Sathekge, Mike Machaba
|
|
dc.date.accessioned |
2022-07-22T06:32:18Z |
|
dc.date.available |
2022-07-22T06:32:18Z |
|
dc.date.issued |
2022-04 |
|
dc.description.abstract |
Prostate adenocarcinoma (PCa) is a leading cause of mortality. Black males with high-risk PCa have a poorer prognosis compared to white males. Patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 and 2 PCa have little potential for metastases post radical prostatectomy. 68Gallium prostate specific membrane antigen (68Ga-PSMA) PET/CT imaging for metastatic PCa is superior to conventional imaging in staging high-risk PCa. No strong evidence is available to support imaging low-risk patients. We aimed to evaluate the value of 68Ga-PSMA PET/CT in black and white South African (BSA and WSA) males with GG1 and 2 PCa at initial staging. We evaluated 25 WSA and 123 BSA males. The image findings were correlated with prostate specific antigen (PSA). PSA levels significantly correlated with both primary tumor and whole-body PSMA-tumor volume (PSMA-TV) and were higher in BSA males. No differences were noted in the occurrence of metastases; however, PSA, seminal vesicle invasion and black race predicted metastases. Our findings suggest higher PSMA expression and tumor burden in BSA with histologically low-risk PCa, and future research with immunohistochemistry evaluation will be essential to confirm these findings |
en_US |
dc.description.department |
Nuclear Medicine |
en_US |
dc.description.uri |
http://www.mdpi.com/journal/biomedicines |
en_US |
dc.identifier.citation |
Maserumule LC, Mokoala KMG, van de Wiele C, Popoola G, Hlongwa KN, Ndlovu H, Maes A, Vorster M, Sathekge MM. 68Ga-PSMA-11 PET/CT Initial Staging in Black and White South African Males with ISUP Grade Group 1 and 2 Prostate Adenocarcinoma. Biomedicines. 2022 Apr 12;10(4):882. doi: 10.3390/biomedicines10040882. |
en_US |
dc.identifier.issn |
2227-9059 (online) |
|
dc.identifier.other |
10.3390/biomedicines10040882 |
|
dc.identifier.uri |
https://repository.up.ac.za/handle/2263/86383 |
|
dc.language.iso |
en |
en_US |
dc.publisher |
MDPI |
en_US |
dc.rights |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. |
en_US |
dc.subject |
68Ga-PSMA PET/CT |
en_US |
dc.subject |
Prostate cancer |
en_US |
dc.subject |
Racial differences |
en_US |
dc.subject |
Prostate adenocarcinoma (PCa) |
en_US |
dc.subject |
68Gallium prostate specific membrane antigen (68Ga-PSMA) |
en_US |
dc.subject |
Positron emission tomography/computed tomography (PET/CT) |
en_US |
dc.subject |
Prostate specific antigen (PSA) |
en_US |
dc.subject |
Prostate specific membrane antigen (PSMA) |
en_US |
dc.title |
Ga-68-PSMA-11 PET/CT initial staging in black and white South African males with ISUP grade group 1 and 2 prostate adenocarcinoma |
en_US |
dc.type |
Article |
en_US |